Market Overview:
The global plasma protein binding assay market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for plasma protein binding assays from pharmaceutical and biotechnology companies, contract research organizations (CROs), and other research institutes. Based on type, the global plasma protein binding assay market is segmented into equilibrium dialysis, ultrafiltration, ultracentrifugation, and gel filtration chromatography. Of these segments, equilibrium dialysis held the largest share of the global market in 2017. This segment is projected to grow at a CAGR of 7.8% during the forecast period owing to its ability to measure both high-molecular-weight (HMW) and low-molecular-weight (LMW) proteins with high accuracy.
Product Definition:
A plasma protein binding assay is a laboratory test used to measure the amount of a drug that is bound to proteins in the blood. The results of this assay can help clinicians determine how much of a drug is available to interact with its target tissue and how much might be eliminated from the body through other routes, such as metabolism or excretion. This information can be helpful in tailoring drug therapy for individual patients.
Equillibrium Dialysis:
Equillibrium dialysis is a technique used to eliminate the blood urea nitrogen (BUN) and creatinine from the blood. It is an invasive procedure that involves insertion of a catheter into the vein of patient and then artificial membrane formation by using peritoneal fluid as medium.
Ultrafiltration:
Ultrafiltration is a membrane technology that separates micro-organisms and their toxins from the blood or milk. It works by creating a ultrafilter with an ultrafilter wall consisting of nanofibers. The micro-organisms are caught in the mesh and their toxins are retained on the filter surface. This technology has wide applications in food, water, biotechnology, chemical industries as well as medical sectors such as kidney dialysis centers among others.
Application Insights:
The pharmaceutical and biotechnology companies dominated the market with a share of over 60.0% in 2017. The segment is expected to witness significant growth during the forecast period, owing to an increase in demand for plasma protein binding assays by various manufacturers for drug discovery and development purposes. In addition, factors such as growing R&D expenditure by major players such as Pfizer & Merck KGaA; Novo Nordisk A/S; Roche Ltd.; sanofi-aventis; and others are anticipated to boost product demand over the next seven years.
The contract research organization (CRO) application segment is expected to expand at a CAGR of XX% from 2018 to 2030 due to an increase in CRO partnerships with several testing laboratories including Promega Corporation; Biodesix, Inc.; Genome Institute Limited (GIL); Qiagen GmbH & Co., Kgaa; PerkinElmer Inc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of companies involved in R&D activities and high adoption rate for advanced technologies across this region. Moreover, increasing government funding for plasma protein research is also expected to contribute toward regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments as well as private organizations and an increase in disposable income resulting from economic development. In addition, growing awareness about blood disorders among people is also expected to drive regional demand during the same period (from 2018). Furthermore, an increase in medical tourism due to better healthcare infrastructure along with low pricing structure will boost industry expansion further (during 2018-2030).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The number of people suffering from chronic diseases such as diabetes, heart disease, and cancer is on the rise, which is expected to drive the demand for plasma protein binding assays in the coming years.
- Technological advancements: The development of novel technologies has led to a significant increase in the accuracy and efficiency of plasma protein binding assays over traditional methods. This is likely to boost demand for these tests in the coming years.
- Growing awareness about personalized medicine: There has been a growing trend towards personalized medicine in recent years due to its many advantages over traditional treatment methods. Plasma protein binding assays are an important part of personalized medicine and are likely to see increased demand as this trend continues to grow in popularity.
Scope Of The Report
Report Attributes
Report Details
Report Title
Plasma Protein Binding Assay Market Research Report
By Type
Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography
By Application
Pharmaceutical & Biotechnology Companies, Contract Research Organization
By Companies
3B Pharmaceuticals, Absorption Systems, Admecell, Biotium, Danaher Corporation, Eurofins Scientific, GE Healthcare, Htdialysis, Merck, Sovicell GmbH, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
144
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Plasma Protein Binding Assay Market Report Segments:
The global Plasma Protein Binding Assay market is segmented on the basis of:
Types
Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical & Biotechnology Companies, Contract Research Organization
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3B Pharmaceuticals
- Absorption Systems
- Admecell
- Biotium
- Danaher Corporation
- Eurofins Scientific
- GE Healthcare
- Htdialysis
- Merck
- Sovicell GmbH
- Thermo Fisher Scientific
Highlights of The Plasma Protein Binding Assay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Equillibrium Dialysis
- Ultrafiltration
- Ultracentrifugation
- Gel Filtration Chromatography
- By Application:
- Pharmaceutical & Biotechnology Companies
- Contract Research Organization
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plasma Protein Binding Assay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The plasma protein binding assay is a laboratory test used to measure the amount of a specific plasma protein that is bound to a particular drug or other molecule. The test can be used to determine the potential therapeutic efficacy of a drug candidate by determining how well it binds to one or more plasma proteins.
Some of the major players in the plasma protein binding assay market are 3B Pharmaceuticals, Absorption Systems, Admecell, Biotium, Danaher Corporation, Eurofins Scientific, GE Healthcare, Htdialysis, Merck, Sovicell GmbH, Thermo Fisher Scientific.
The plasma protein binding assay market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plasma Protein Binding Assay Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Plasma Protein Binding Assay Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Plasma Protein Binding Assay Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Plasma Protein Binding Assay Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Plasma Protein Binding Assay Market Size & Forecast, 2018-2028
4.5.1 Plasma Protein Binding Assay Market Size and Y-o-Y Growth
4.5.2 Plasma Protein Binding Assay Market Absolute $ Opportunity
Chapter 5 Global Plasma Protein Binding Assay Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Plasma Protein Binding Assay Market Size Forecast by Type
5.2.1 Equillibrium Dialysis
5.2.2 Ultrafiltration
5.2.3 Ultracentrifugation
5.2.4 Gel Filtration Chromatography
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Plasma Protein Binding Assay Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Plasma Protein Binding Assay Market Size Forecast by Applications
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Contract Research Organization
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Plasma Protein Binding Assay Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Plasma Protein Binding Assay Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Plasma Protein Binding Assay Analysis and Forecast
9.1 Introduction
9.2 North America Plasma Protein Binding Assay Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Plasma Protein Binding Assay Market Size Forecast by Type
9.6.1 Equillibrium Dialysis
9.6.2 Ultrafiltration
9.6.3 Ultracentrifugation
9.6.4 Gel Filtration Chromatography
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Plasma Protein Binding Assay Market Size Forecast by Applications
9.10.1 Pharmaceutical & Biotechnology Companies
9.10.2 Contract Research Organization
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Plasma Protein Binding Assay Analysis and Forecast
10.1 Introduction
10.2 Europe Plasma Protein Binding Assay Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Plasma Protein Binding Assay Market Size Forecast by Type
10.6.1 Equillibrium Dialysis
10.6.2 Ultrafiltration
10.6.3 Ultracentrifugation
10.6.4 Gel Filtration Chromatography
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Plasma Protein Binding Assay Market Size Forecast by Applications
10.10.1 Pharmaceutical & Biotechnology Companies
10.10.2 Contract Research Organization
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Plasma Protein Binding Assay Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Plasma Protein Binding Assay Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Plasma Protein Binding Assay Market Size Forecast by Type
11.6.1 Equillibrium Dialysis
11.6.2 Ultrafiltration
11.6.3 Ultracentrifugation
11.6.4 Gel Filtration Chromatography
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Plasma Protein Binding Assay Market Size Forecast by Applications
11.10.1 Pharmaceutical & Biotechnology Companies
11.10.2 Contract Research Organization
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Plasma Protein Binding Assay Analysis and Forecast
12.1 Introduction
12.2 Latin America Plasma Protein Binding Assay Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Plasma Protein Binding Assay Market Size Forecast by Type
12.6.1 Equillibrium Dialysis
12.6.2 Ultrafiltration
12.6.3 Ultracentrifugation
12.6.4 Gel Filtration Chromatography
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Plasma Protein Binding Assay Market Size Forecast by Applications
12.10.1 Pharmaceutical & Biotechnology Companies
12.10.2 Contract Research Organization
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Plasma Protein Binding Assay Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Plasma Protein Binding Assay Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Plasma Protein Binding Assay Market Size Forecast by Type
13.6.1 Equillibrium Dialysis
13.6.2 Ultrafiltration
13.6.3 Ultracentrifugation
13.6.4 Gel Filtration Chromatography
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Plasma Protein Binding Assay Market Size Forecast by Applications
13.10.1 Pharmaceutical & Biotechnology Companies
13.10.2 Contract Research Organization
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Plasma Protein Binding Assay Market: Competitive Dashboard
14.2 Global Plasma Protein Binding Assay Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3B Pharmaceuticals
14.3.2 Absorption Systems
14.3.3 Admecell
14.3.4 Biotium
14.3.5 Danaher Corporation
14.3.6 Eurofins Scientific
14.3.7 GE Healthcare
14.3.8 Htdialysis
14.3.9 Merck
14.3.10 Sovicell GmbH
14.3.11 Thermo Fisher Scientific
